source
- STAT+: PhRMA taps Eric Cantor as new CEOEric Cantor, a former GOP House majority leader, is taking the helm of PhRMA at a challenging time for the industry.STAT · 1mo ago↗ source
- UniQure tumbles with latest data for Huntington’s gene therapyAnalysts guessed that investors wanted to see stronger durability results at a four-year check-in of the key trial supporting a potential approval of "AMT-130."BioPharma Dive · 1mo ago↗ source
- UniQure crashes as Huntington’s gene therapy shows less slowing of disease at 4 yearsThe results are nevertheless “unprecedented,” UniQure executives said on an investor call Tuesday, emphasizing that the updated natural history database used as the control group for the Phase 1/2…BioSpace · 1mo ago↗ source